1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. Oklahoma >
  6. Cytovance Biologics

Cytovance Biologics - Ownership and Business Overview

Life ScienceCompany

Cytovance Biologics Ownership

Who owns Cytovance Biologics?

Cytovance Biologics is owned by Shenzhen Hepalink Pharmaceutical Group. It was acquired on August 24, 2015.

Was Cytovance Biologics formerly PE-backed?

Yes. Cytovance Biologics was formerly owned by 2 private investors.

Cytovance Biologics Business Overview

Where is Cytovance Biologics headquartered?

Cytovance Biologics is headquartered in Oklahoma City, Oklahoma.

What sector is Cytovance Biologics in?

Cytovance Biologics is a life science company.

When was Cytovance Biologics founded?

Cytovance Biologics was founded in 2003.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Subscribe to Mergr to view all 294 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 262 by strategics.

Cytovance Biologics, Inc.

800 Research Parkway, Suite 200,
Oklahoma City, Oklahoma 73104
United States,
(405) 319-8310
www.cytovance.com

Cytovance is a contract manufacturing organization of mammalian and microbial biologics. The company works with biotechnology and pharmaceutical companies in the development and manufacturing of proteins, antibodies, and cell-based therapeutic products. Cytovance supports its customers from clinical development to commercial launch in domestic and international markets.


Company Summary

SECTOR

Life Science

Established

2003

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Cytovance Biologics

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal